Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Trials|December 14, 2016
The RESPITE trial: remifentanil intravenously administered patient-controlled analgesia (PCA) versus pethidine intramuscular injection for pain relief in labour: study protocol for a randomised controlled trialMatthew Wilson, Christine MacArthur, Fang Gao Smith, et al.
BMC Medical Research Methodology|June 3, 2024
Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristicsBabak Choodari-Oskooei, Alexandra Blenkinsop, Kelly Handley, et al.
Lancet (London, England)|August 18, 2018
Intravenous remifentanil patient-controlled analgesia versus intramuscular pethidine for pain relief in labour (RESPITE): an open-label, multicentre, randomised controlled trialMatthew J A Wilson, Christine MacArthur, Catherine A Hewitt, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complicationsRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
Plos One|March 13, 2025
Structured follow-up pathway to address unmet needs after transient ischaemic attack and minor stroke (SUPPORT TIA): Feasibility study and process evaluationGrace M Turner, Melanie Calvert, Robbie Foy, et al.
Alimentary Pharmacology & Therapeutics|April 17, 2025
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial)Dhiraj Tripathi, Kelly Handley, Lisa Holden, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's diseaseRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancerGordon Hutchins, Katie Southward, Kelly Handley, et al.
Histopathology|July 27, 2017
Intratumoral stromal morphometry predicts disease recurrence but not response to 5-fluorouracil-results from the QUASAR trial of colorectal cancerGordon G A Hutchins, Darren Treanor, Alexander Wright, et al.
The British Journal of Radiology|August 23, 2025
CT Staging Performance in an International Trial of Neoadjuvant Chemotherapy for locally advanced Colon cancerJames R Platt, Faye Elliott, Kelly Handley, et al.
Pageof 3